Manager, HCP Marketing Strategy & Launch Lead, T2D (Hybrid)

Insulet Corporation is one of the fastest growing medical device companies thanks to the global success of the Omnipod® Insulin Management System in reducing the daily burden for people living with diabetes.

The Manager, HCP Marketing Strategy & Launch Excellence, T2D is responsible for translating global marketing strategy into U.S. specific go-to-market strategy to drive confidence and willingness to prescribe with primary care providers, nurse practitioners, physician assistants, and other HCPs serving patients with both type 1 and type 2 diabetes.  They are responsible for working across downstream marketing teams to translate the go-to-market strategy into actionable plans.  They are also the HCP launch lead on the next generation fully-closed loop innovation for the US.  They also work closely with the Senior Manager, HCP Marketing Strategy & Launch Excellence, T1D to develop initiatives to accelerate share growth and market penetration.

Responsibilities:

• Lead launch excellence for next generation fully-closed loop technology, focused on US HCP marketing plans

• Partner with upstream marketing to develop other in-market initiatives including new claims, evidence dissemination, and competitive tactics across HCP marketing channels to grow share of Rx amongst US HCPs

• Partner with the T2 segment marketing team to create pilot initiatives to drive consideration and AID utilization amongst primary care providers, including market priming and practice building

• Partner with downstream marketing teams who develop channel plans for HCPs, including media, PR, and field sales communication, in alignment with overall launch / initiative strategy

• Lead competitive strategy to defend and deepen Omnipod’s T2D leadership

• Accountable for generating insights and deepening relationships with primary care specialties including KOL engagements, advisory boards, advocacy and society engagement, and specialty-specific promotional and educational tactics

• Lead HCP marketing collaboration with our CGM partners, including co-promotion and joint education sessions

Education and Experience:

• Bachelor’s degree required, preferably in Business or Marketing

• At least 8-10 years of experience between upstream and downstream marketing in the healthcare industry (medical device, digital health, pharmaceuticals, etc.) or MBA with 5 years of related experience

• Experience launching products to healthcare providers required

• Experience delivering HCP marketing plans in collaboration with product and brand strategy teams

• Experience with HCP engagement, advisory boards, and society/advocacy partnership

Preferred Skills & Competencies:

• Ability to influence without authority and develop strong cross-functional relationships

• Agility and a demonstrated sense of ownership to deliver on results in a fast-paced environment

• Proven track record leading product launches and lifecycle marketing initiatives

• Strong analytic skills and the ability to translate complex data into actionable insights for senior leadership and cross-functional audiences

• Experience in the diabetes industry or within chronic disease management is not required but preferred

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable and waterproof Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero finger sticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

Studies have demonstrated the clinical and lifestyle advantages of insulin pump therapy over multiple daily insulin injections (MDI). However, many people still choose MDI therapy largely due to the complexity, cost, and inconvenience of conventional pump technology. The Omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. By breaking down the barriers to insulin pump therapy, Insulet hopes to provide both a super